You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

PI3KCA Mutation Positive/PTEN

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Advanced Cancers, Solid Tumors Trial in Houston (Pazopanib, Everolimus)

Active, not recruiting
  • Advanced Cancers
  • Solid Tumors
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Dec 16, 2022

Metastatic Breast Cancer Trial in Spain (Ipatasertib, Trastuzumab, Pertuzumab)

Recruiting
  • Metastatic Breast Cancer
  • Badalona, Barcelona, Spain
  • +9 more
Oct 24, 2022

Carcinoma, Squamous Cell of Head and Neck Trial in France (Copanlisib, Cetuximab)

Terminated
  • Carcinoma, Squamous Cell of Head and Neck
  • Angers, France
  • +6 more
Mar 24, 2021

Anatomic Stage IV Breast Cancer AJCC v8, HER2-Positive Breast Carcinoma, Metastatic Breast Carcinoma Trial in United States

Recruiting
  • Anatomic Stage IV Breast Cancer AJCC v8
  • +2 more
  • Los Angeles, California
  • +4 more
Jul 19, 2022

PIK3CA Mutation, Solid Tumor, Adult, HER2-negative Breast Cancer Trial (RLY-5836, Fulvestrant, Palbociclib)

Not yet recruiting
  • PIK3CA Mutation
  • +7 more
  • (no location specified)
Mar 7, 2023

HER2+ Breast Cancer Trial in Xi'an (Trastuzumab, Pertuzumab, Nab paclitaxel)

Recruiting
  • HER2+ Breast Cancer
  • Xi'an, Shaanxi, China
  • +1 more
Jun 20, 2022

Advanced Unresectable or Metastatic Solid Malignancy Trial in United States (Entrectinib, Inavolisib, Alectinib)

Recruiting
  • Advanced Unresectable or Metastatic Solid Malignancy
  • Birmingham, Alabama
  • +50 more
Aug 10, 2022

Breast Cancer Trial in Italy (Ribociclib, Letrozole, Alpelisib)

Active, not recruiting
  • Breast Cancer
  • Casale Monferrato, AL, Italy
  • +40 more
Dec 3, 2021

HER2-positive Breast Cancer Trial in Rome (PIK3CA analysis)

Active, not recruiting
  • HER2-positive Breast Cancer
  • PIK3CA analysis
  • Rome, RM, Italy
    Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Feb 20, 2023

Advanced Solid Malignancy, Safety and Tolerability, Pharmacokinetics Trial in Worldwide (AZD5363)

Active, not recruiting
  • Advanced Solid Malignancy
  • +13 more
  • Los Angeles, California
  • +33 more
Dec 22, 2022

Advanced Breast Carcinoma, Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage IIIA Breast Cancer AJCC v8 Trial in Houston

Recruiting
  • Advanced Breast Carcinoma
  • +17 more
  • Houston, Texas
    M D Anderson Cancer Center
Dec 5, 2022

HR+/HER2- Advanced Breast Cancer, Targeted Therapy Trial in Beijing (Everolimus, Chidamide, Endocrine therapy)

Recruiting
  • HR+/HER2- Advanced Breast Cancer
  • Targeted Therapy
  • Beijing, Beijing, China
    National Cancer Center/National Clinical Research Center for Can
Aug 1, 2023

Triple Negative Breast Tumors Trial in Worldwide (alpelisib, , nab-paclitaxel)

Active, not recruiting
  • Triple Negative Breast Neoplasms
  • Los Alamitos, California
  • +154 more
Jan 12, 2023

Patients With a Constitutional Alteration of the PTEN Gene

Not yet recruiting
  • PTEN Gene Mutation
    • (no location specified)
    Nov 17, 2022

    Endometrial Cancer, Ovarian Cancer Trial in Houston (Copanlisib, fulvestrant)

    Recruiting
    • Endometrial Cancer
    • Ovarian Cancer
    • Houston, Texas
      M D Anderson Cancer Center
    Sep 27, 2022

    Non Small Cell Lung Cancer Trial in Worldwide (AZD9291)

    Active, not recruiting
    Has Results
    • Non Small Cell Lung Cancer
    • La Jolla, California
    • +43 more
    Nov 25, 2022

    Advanced Breast Cancer Trial in Thalassery (Alpelisib, Fulvestrant)

    Recruiting
    • Advanced Breast Cancer
    • Thalassery, Kerala, India
      Novartis Investigative Site
    Nov 21, 2022

    Fallopian Tube Endometrioid Adenocarcinoma, Fallopian Tube High Grade Serous Adenocarcinoma, Ovarian Endometrioid Adenocarcinoma

    Recruiting
    • Fallopian Tube Endometrioid Adenocarcinoma
    • +17 more
    • Biopsy
    • +3 more
    • Augusta, Georgia
    • +4 more
    Jan 25, 2023

    Anatomic Stage IV Breast Cancer AJCC v8, Hormone Receptor-Positive Breast Carcinoma, Metastatic Breast Carcinoma Trial in United

    Recruiting
    • Anatomic Stage IV Breast Cancer AJCC v8
    • +4 more
    • Birmingham, Alabama
    • +12 more
    Nov 9, 2022

    Breast Cancer, Advanced Breast Cancer, Metastatic Breast Cancer Trial (MEN1611, Eribulin)

    Not yet recruiting
    • Breast Cancer
    • +2 more
    • (no location specified)
    Apr 12, 2023

    CDK4/6 Inhibitors Combined With Endocrine Therapy and Subsequent

    Not yet recruiting
    • Breast Cancer
    • +3 more
    • Different treatment regimens following progression on CDK4/6 inhibitors.
    • (no location specified)
    Sep 5, 2023

    Frequency of Occult Breast Cancer After Prophylactic Mastectomy

    Recruiting
    • Genetic Predisposition
    • +3 more
    • Histopathological confirmation
    • Karachi, Sindh, Pakistan
      Aga Khan University Hospital
    Mar 15, 2023

    Advanced Malignant Solid Tumor, Metastatic Malignant Solid Tumor, Refractory Malignant Solid Tumor Trial in Canada, United

    Recruiting
    • Advanced Malignant Solid Neoplasm
    • +2 more
    • Biopsy
    • +6 more
    • Boston, Massachusetts
    • +5 more
    Jan 7, 2023

    Triple Negative Breast Cancer, Metastatic Breast Cancer, Mutation Trial in Shanghai (Everolimus, Investigator's Choice of

    Not yet recruiting
    • Triple Negative Breast Cancer
    • +2 more
    • Shanghai, Shanghai, China
      Fudan University Shanghai Cancer Center
    Jul 25, 2023

    Solid Tumor, ARID1A Gene Mutation Trial in Greenville (Tazemetostat)

    Suspended
    • Solid Tumor
    • ARID1A Gene Mutation
    • Greenville, South Carolina
      Prisma Health Cancer Institute
    Jan 10, 2023